AlloFinder: a strategy for allosteric modulator discovery and allosterome analyses
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Allostery tweaks innumerable biological processes and plays a fundamental role in human disease and drug discovery. Exploration of allostery has thus been regarded as a crucial requirement for research on biological mechanisms and the development of novel therapeutics. Here, based on our previously developed allosteric data and methods, we present an interactive platform called AlloFinder that identifies potential endogenous or exogenous allosteric modulators and their involvement in human allosterome. AlloFinder automatically amalgamates allosteric site identification, allosteric screening and allosteric scoring evaluation of modulator-protein complexes to identify allosteric modulators, followed by allosterome mapping analyses of predicted allosteric sites and modulators in human proteome. This web server exhibits prominent performance in the reemergence of allosteric metabolites and exogenous allosteric modulators in known allosteric proteins. Specifically, AlloFinder enables identification of allosteric metabolites for metabolic enzymes and screening of potential allosteric compounds for disease-related targets. Significantly, the feasibility of AlloFinder to discover allosteric modulators was tested in a real case of signal transduction and activation of transcription 3 (STAT3) and validated by mutagenesis and functional experiments. Collectively, AlloFinder is expected to contribute to exploration of the mechanisms of allosteric regulation between metabolites and metabolic enzymes, and to accelerate allosteric drug discovery. The AlloFinder web server is freely available to all users at http://mdl.shsmu.edu.cn/ALF/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
Irwin, J. J., & Shoichet, B. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049714+ · Cited by 4,058 · cited 4×
“For virtual database screening, the users can select one of the following databases, including Endogenous Ligands, ChEMBL Diversity (33), ZINC Diversity (34), SPECS Diversity (http: D ow nloaded from https://academ ic.oup.com /nar/article-abstract/46/W 1/W 451/4994952 by guest on 05 M ay 2019 Figure 1.”
MethodInfluentialBenchmarking sets for molecular docking.
Huang, N., Shoichet, B. K., & Irwin, J. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0608356 · Cited by 1,318 · cited 1×
“The enrichment factor (EF) is the most common metrics for screening, which is the concentration of the known ligands among the top-scoring hits compared to their concentration throughout the entire library (36).”
BackgroundThe ensemble nature of allostery
Motlagh, H. N., Wrabl, J. O., Li, J., & Hilser, V. J. (2014) · Nature · doi:10.1038/nature13001 · Cited by 1,247
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Comparative evaluation of 11 scoring functions for molecular docking.
Wang, R., Lu, Y., & Wang, S. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0203783 · Cited by 849 · cited 1×
“Afterward, conformational sampling of an ensemble of docked conformations for each compound from the pharmacophore-filtered subset is executed using the genetic algorithm from AutoDock Vina (31,32).”
MethodSelf-citationEmerging paradigms in GPCR allostery: implications for drug discovery
Wootten, D., Christopoulos, A., & Sexton, P. M. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4052 · Cited by 498 · cited 1×
“Meanwhile, exogenous allosteric modulators (also allosteric compounds produced from outside organism) (11), by targeting the structural diversity of allosteric sites, have”
BackgroundRas Conformational Ensembles, Allostery, and Signaling
Lu, S., Jang, H., Muratcioglu, S., Gursoy, A., Keskin, O., Nussinov, R., & Zhang, J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00542 · Cited by 355
Self-citationExtensive In Vivo Metabolite-Protein Interactions Revealed by Large-Scale Systematic Analyses
Li, X., Gianoulis, T. A., Yip, K. Y., Gerstein, M., & Snyder, M. (2010) · Cell · doi:10.1016/j.cell.2010.09.048 · Cited by 237
Principles of Allosteric Interactions in Cell Signaling
Nussinov, R., Tsai, C.-J., & Liu, J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja510028c · Cited by 154
Zhang, T., Kee, W. H., Seow, K. T., Fung, W., & Cao, X. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.19.7132-7139.2000 · Cited by 150
ASD v3.0: unraveling allosteric regulation with structural mechanisms and biological networks
Shen, Q., Wang, G., Li, S., Liu, X., Lu, S., Chen, Z., Song, K., Yan, J., Geng, L., Huang, Z., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv902 · Cited by 122
Self-citationA Novel Sequence in the Coiled-coil Domain of Stat3 Essential for Its Nuclear Translocation
Ma, J., Zhang, T., Novotny-Diermayr, V., Tan, A. L. C., & Cao, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304196200 · Cited by 110
Recent computational advances in the identification of allosteric sites in proteins
Lu, S., Huang, W., & Zhang, J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.07.012 · Cited by 102 · cited 1×
“An alternative approach is the development of computational methods to identify allosteric sites (20,21).”
BackgroundSelf-citationThe Metabolome-Wide Association Study: a new look at human disease risk factors
Nicholson, J. K., Holmes, E., & Elliott, P. (2008) · Journal of Proteome Research · doi:10.1021/pr8005099 · Cited by 93
Structure-based prediction of protein allostery
Greener, J. G., & Sternberg, M. J. (2018) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2017.10.002 · Cited by 91
Are there physicochemical differences between allosteric and competitive ligands?
Smith, R. D., Lu, J., & Carlson, H. A. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005813 · Cited by 27 · cited 1×
“Furthermore, it is well established that the physicochemical characteristics of allosteric modulators are divergent from orthosteric ligands (25,26).”
Background
Cited by
LncRNA-encoded polypeptide ASRPS inhibits triple-negative breast cancer angiogenesis
Wang, Y., Wu, S., Zhu, X., Zhang, L., Deng, J., Li, F., Guo, B., Zhang, S., Wu, R., Zhang, Z., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190950 · Cited by 231
Ni, D., Lu, S., & Zhang, J. (2019) · Medicinal Research Reviews · doi:10.1002/med.21585 · Cited by 116
Self-citationAlphaFold, allosteric, and orthosteric drug discovery: Ways forward
Nussinov, R., Zhang, M., Liu, Y., & Jang, H. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103551 · Cited by 96
SHF Acts as a Novel Tumor Suppressor in Glioblastoma Multiforme by Disrupting STAT3 Dimerization
Wang, J., Huang, Z., Ji, L., Chen, C., Wan, Q., Xin, Y., Pu, Z., Li, K., Jiao, J., Yin, Y., et al. (2022) · Advanced Science · doi:10.1002/advs.202200169 · Cited by 22
Dynamic Protein Allosteric Regulation and Disease
Nussinov, R., Tsai, C.-J., & Jang, H. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-8719-7_2 · Cited by 18
Metadata
- Authors
- Huang, M., Song, K., Liu, X., Lu, S., Shen, Q., Wang, R., Gao, J., Hong, Y., Li, Q., Ni, D., Xu, J., Chen, G., & Zhang, J.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-05-11
- Volume
- 46
- Issue
- W1
- Pages
- W451-W458
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2802520483
- Cited by
- 93
- References
- 17
- FWCI
- 8.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.